From: Sex differences in cancer survival in Estonia: a population-based study
All ages (age-adjusted) | 15–44 | 45–54 | 55–64 | 65–74 | ≥75 | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cancer site | RSR (W) % | RSR (M) % | RSR(W) minus RSR(M) | RSR (W) % | RSR (M) % | RSR(W) minus RSR(M) | RSR (W) % | RSR (M) % | RSR(W) minus RSR(M) | RSR (W) % | RSR (M) % | RSR(W) minus RSR(M) | RSR (W) % | RSR (M) % | RSR(W) minus RSR(M) | RSR (W) % | RSR (M) % | RSR(W) minus RSR(M) |
Mouth, pharynx | 52 | 30 | 22* | 62 | 31 | 31* | 55 | 26 | 29* | 54 | 22 | 32* | 48 | 37 | 11 | 51 | 30 | 21 |
Stomach | 23 | 20 | 3 | 26 | 31 | −5 | 29 | 22 | 7 | 28 | 24 | 4 | 23 | 18 | 5 | 16 | 16 | 0 |
Colon | 51 | 50 | 1 | 58 | 60 | −2 | 52 | 53 | −1 | 52 | 47 | 5 | 52 | 52 | 0 | 46 | 46 | 0 |
Rectum | 46 | 42 | 4 | 42 | 42 | 0 | 53 | 41 | 12 | 53 | 50 | 3 | 49 | 48 | 1 | 34 | 31 | 3 |
Pancreas | 6 | 5 | 1 | 15 | 17 | −2 | 12 | 5 | 7 | 5 | 6 | −1 | 5 | 2 | 3 | 3 | 5 | −2 |
Lung | 14 | 9 | 5* | 28 | 15 | 13 | 23 | 10 | 13* | 15 | 10 | 5 | 9 | 8 | 1 | 11 | 6 | 5 |
Skin melanoma | 73 | 56 | 17* | 82 | 66 | 16* | 75 | 60 | 15 | 69 | 51 | 18* | 71 | 60 | 11 | 64 | 36 | 28 |
Kidney | 62 | 54 | 8* | 82 | 64 | 18 | 77 | 56 | 21* | 69 | 58 | 11* | 56 | 56 | 0 | 51 | 45 | 6 |
Bladder | 65 | 63 | 2 | 78 | 88 | −10 | 72 | 80 | −8 | 73 | 66 | 7 | 67 | 60 | 7 | 50 | 50 | 0 |